TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts October 30, 1981
TCL Archive FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response June 17, 1988